Skip to content

Heavy ropivacaine with and without dexmedetomidine as an adjuvant in spinal anaesthesia for caesarean section

Effect of hyperbaric ropivacaine with and without dexmedetomidine as an adjuvant in spinal anaesthesia for caesarean section:A prospective observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/11/059631
Enrollment
60
Registered
2023-11-07
Start date
Unknown
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P00-P96- Certain conditions originating in the perinatal period

Interventions

Intervention1: NIL: NIL

Sponsors

Mohammadfaizan kanuga
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients posted for elective or emergency caesarean section receiving spinal anaesthesia 2) Patients in the age group of 18-40 years 3)Patients having height of 145-165cm 4) Patients belonging to ASA grade I, II or III 5) Patients giving written informed consent

Exclusion criteria

Exclusion criteria: 1)Contraindication to spinal anaesthesia (Patient Refusal, Coagulopathy, localized infection and neurological diseases, allergy to study drugs) 2)Patient having major cardio-respiratory disorders or major hepato-renal disorders 3)Multifetal pregnancies 4)Suspected fetal abnormalities 5)Fetal compromised 6)Severe PIH

Design outcomes

Primary

MeasureTime frame
1)Onset and duration of sensory &motor blockade 2)Duration of post operative analgesia and 24 hours analgesic requirement Timepoint: 24 hours

Secondary

MeasureTime frame
1)Hemodynamic parameters 2)Adverse effects and side effects Timepoint: 24 hours

Countries

India

Contacts

Public ContactDr.Bansari Kantharia

Government medical college new civil hospital surat gujarat

bansarikantharia@gmail.com9825690177

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026